FERRACCIOLI, Gianfranco
 Distribuzione geografica
Continente #
AS - Asia 87
NA - Nord America 36
SA - Sud America 16
EU - Europa 12
AF - Africa 6
Totale 157
Nazione #
SG - Singapore 46
US - Stati Uniti d'America 35
BR - Brasile 14
CN - Cina 14
VN - Vietnam 14
HK - Hong Kong 10
ZA - Sudafrica 5
NL - Olanda 4
ES - Italia 3
BD - Bangladesh 1
CA - Canada 1
CO - Colombia 1
DE - Germania 1
GB - Regno Unito 1
ID - Indonesia 1
IN - India 1
IT - Italia 1
KE - Kenya 1
PT - Portogallo 1
RU - Federazione Russa 1
UY - Uruguay 1
Totale 157
Città #
Singapore 24
Hong Kong 10
Santa Clara 6
Ashburn 5
Beijing 5
Hanoi 5
Ho Chi Minh City 4
Johannesburg 4
Boardman 3
Columbus 3
Dallas 2
Orem 2
Acalanes Ridge 1
Bandung 1
Belzoni 1
Canoas 1
Chennai 1
Conselheiro Lafaiete 1
Cuiabá 1
Da Nang 1
Guarulhos 1
Haiphong 1
Hangzhou 1
Hefei 1
Lisbon 1
London 1
Los Angeles 1
Maldonado 1
Manassas 1
Montreal 1
Nairobi 1
Naples 1
Nova Crixás 1
Nuremberg 1
Pinheiral 1
Pouso Alegre 1
Pretoria 1
Qingdao 1
Reston 1
Salvador 1
Santiago de Cali 1
Sirinhaém 1
São Paulo 1
Teresina 1
Thái Bình 1
Umuarama 1
Viamão 1
Totale 108
Nome #
Anti-TNF Therapy Is Associated with an Increase in Serious Infections in Patients with Spondyloarthritis (SpA), Especially during the First 12 Monts of Treatment: Results from the GISEA Registry 47
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 41
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients 39
Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries 37
Totale 164
Categoria #
all - tutte 677
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 677


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20246 0 0 0 0 0 0 0 0 0 3 0 3
2024/202552 0 2 4 0 2 4 2 7 5 7 6 13
2025/2026106 17 18 19 20 30 2 0 0 0 0 0 0
Totale 164